english.prescrire.org > Spotlight > 100 most recent

Spotlight

Every month, the subjects in Prescrire’s Spotlight.

100 most recent :  1 | 10 | 20 | 30 | 40 | 50 | 60 | 70 | 80 | 90

European Commission: lobbyists block nutritional labelling

Dupilumab (Dupixent°) in prurigo nodularis

Netarsudil (Rhokiinsa°) or netarsudil + latanoprost (Roclanda°) in chronic glaucoma: not acceptable

Zanubrutinib (Brukinsa°) in certain haematological malignancies

Methadone: an analysis of adverse effects reported in France

Mediator° trial appeal: a judgement that better reflects the harm done

New data after marketing authorisation: European Commission consultation

Non-comparative trials for marketing authorisations: EMA consultation

Drug shortages: Prescrire calls for transparency

A tale of risk

1 | 10 | 20 | 30 | 40 | 50 | 60 | 70 | 80 | 90